A retrospective review of the esperience of one of us (N.J.P.) with rhinoplasty was performed. One hundred seventy-three rhinoplasties were performed over a 13-moth period. The patients (139 women and 34 men) ranged in age from 15 to 78 years. One hundred nineteen patientes underwent primary rhinoplasty (91 women and 28 men), and 54 pátients underwent revision rhinoplasty (48 women and 6 men). These rhinoplasties were with the cartilage delivery technique in patients who demonstrated adequate tip support before surgery. An external splint was placed at the conclusion of surgery and was removed in 1 week, at which time the supratip was vissually assessed and palpated. Postoperative follow-up lasted a minimum of 6 weeks.
Triamcinolone acetonide (10 mg/mL) was injected subcutaneously into the supratip region per the author´s protocol ar 1 week after surgery in 127 patients (73%). The group included 84 (70%) of 119 primary rhinoplasties and 43 (80%) of 54 revision rhinoplasties. Ninety-two (72%) of the 127 patients required a second injection with triamcinolone was made by the surgeon (N.J.P.).
One hundred eight (85%) of the 127 patients who received injections had an acceptable result, with good supratip definition, as judged by the surgeon. Nineteen (15%) of the 127 patients had a less than optimal result, with residual supratip fullness, as jufged by the surgeon. There were no permanent complications from the injections in any of the patients in this series.
